Categories Earnings, Health Care
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG): Q3 2019 Earnings Snapshot
— AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) reported a net loss of $23.62 million or $0.70 per share for the third quarter of 2019, vs. $0.66 per share loss expected
— Revenues dropped to $84.13 million from $122.24 million last year, vs. $88.27 million expected
— Lowered full-year 2019 revenue guidance to $320-$330 million from the earlier outlook of $325-$355 million
— Expects full-year operating loss of $278-$268 million, up from $276 million loss estimated earlier
— Expects adjusted EBITDA loss in the range of $75 million to $65 million for 2019, which is down from the previous forecast of $85-$75 million
Most Popular
Key highlights from Adobe (ADBE) Q2 2021 earnings results
Adobe Systems Incorporated (NASDAQ: ADBE) reported second quarter 2021 earnings results today. Total revenue grew 23% year-over-year to $3.84 billion. GAAP net income was $1.11 billion, or $2.32 per share,
Three factors that bode well for Delta Air Lines (DAL) going forward
Shares of Delta Air Lines Inc. (NYSE: DAL) have gained 45% over the past 12 months and 11% since the beginning of this year. After a particularly distressful period, like
KR Earnings: All you need to know about Kroger Q1 2021 earnings results
The Kroger Co. (NYSE: KR) reported first-quarter 2021 earnings results today. Total company sales were $41.3 billion compared to $41.5 billion in the same period last year. Excluding fuel, sales
